Tag: Definiens

Definiens Launches Cloud-Based Digital Pathology Solution VeriTrova™ to Support Takeda’s Translational and Biomarker Research Efforts

| November 8, 2016 | 0 Comments

Munich, Germany – Nov 7 2016 – Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, announced a program collaboration with Takeda Pharmaceuticals to enable comprehensive tissue-based analysis in clinical trials. Definiens’ products and services deepen the understanding of disease biology and the immune system to advance clinical trials. By using knowledge-driven biomarker analysis […]

Continue Reading

Webinar from Definiens: Integrated Tissue Phenomics® and Big Data for Biomarker Discovery and Test Development

| June 28, 2016 | 0 Comments

Join us for our July 19 webinar! Dr. Ralf Huss, Chief Medical Officer at Definiens, will talk about the usage of Tissue Phenomics to discover relevant patterns in tissue slides that predict drug response or other clinical outcome. You can select from one of two different broadcast times to watch this webinar. Date: Tuesday, July […]

Continue Reading

Tissue Phenomics® at Work for Immuno-oncology and Transplantation Medicine

| June 15, 2016 | 0 Comments

Join Definiens for their June 27 webinar! Prof. Friedrich Feuerhake from Medical School Hanover will be presenting how the Tissue Phenomics methodology is applied to mine clinically annotated image data and discover new features with prognostic value. You can select from one of two different broadcast times to watch this webinar.  Date: Monday, June 27, […]

Continue Reading

Register Now for The International Symposium for Tissue Phenomics®

| February 9, 2016 | 0 Comments

Join Charité, INSERM, Merck, M.I.T., N.I.H., Providence Health Service, University Medical Center Heidelberg to The International Symposium for Tissue Phenomics® Join us at The International Symposium for Tissue Phenomics to take part in the conversation with thought leaders from around the globe on immunotherapy, companion diagnostics, and tissue-based patient stratification for personalized medicine. Dates: April […]

Continue Reading

Register Today for The International Symposium for Tissue Phenomics®

| January 18, 2016 | 0 Comments

Definiens invites you to attend The International Symposium for Tissue Phenomics, happening April 26-27, 2016 in Cambridge, Massachusetts. Enjoy expert presentations on immuno-oncology and big data, valuable panel discussions, all while networking with your peers and other industry experts. Hear speakers from cutting edge organizations such as: Charite INSERM MD Anderson Merck MedImmune MIT NIH Providence […]

Continue Reading

How to Discover Powerful Tissue-based Prognostic Biomarkers for the Benefit of Individual Patients

| November 8, 2015 | 0 Comments

Join us for our November 11 webinar! Dr. Nathalie Harder will be presenting the Tissue Phenomics® methodology to discover new tissue-based diagnostics using image and clinical data and known clinical outcome for the benefit of individual patients. You can select from one of two different broadcast times to watch this webinar. Date: Wednesday, November 11, […]

Continue Reading

Applying Tissue Phenomics® to Clinical Questions for Patient Stratification

| September 13, 2015 | 0 Comments

Join us for our September 23 webinar on Applying Tissue Phenomics® to Clinical Questions for Patient Stratification. Dr. Peter Caie will be presenting how Tissue Phenomics can be utilized to identify previously undiscovered prognostic and predictive image-based features or combinations of features for patient stratification. For your convenience, select from one of two different broadcast […]

Continue Reading

Definiens Strengthens Tissue Phenomics Research with microDimensions’ Technology

| August 16, 2015 | 0 Comments

microDimensions, global provider of state-of-the-art digital pathology software and services, won Definiens as one of their customers. Definiens is the pioneer in Tissue Phenomics® solutions for diagnostics development and commercialization and was recently acquired by MedImmune, the biologics research and development arm of AstraZeneca. As a new customer of microDimensions, Definiens will be combining microDimensions’ […]

Continue Reading

Definiens Releases Biomarker Datafication Services for Oncology Clinical Development

| June 1, 2015 | 0 Comments

New Offering Announced at ASCO 2015 Provides Valuable Data for Clinical Program Decision Making MUNICH- Definiens, the global leader in image analysis for digital pathology and diagnostics, today announced a new suite of Biomarker Datafication Services for oncology clinical development programs. This package of services enables pharmaceutical and biotech companies to gather comprehensive data from their […]

Continue Reading

Tissue Studio® Bundles for Easy Image Analysis

| May 24, 2015 | 0 Comments

Definiens is happy to introduce our new Tissue Studio® bundles that provide the accuracy, ease-of-use, and productivity gains researchers need for their discovery and preclinical studies, right out of the box. Experience a level of image analysis flexibility and scalability that only Definiens can provide. Tissue Studio® Bundles Tissue Studio® Standard – a node-locked configuration that supports 1 […]

Continue Reading

Webinar from Definiens: Clinical Trial Patient Stratification with Quantitative IHC Assays

| April 28, 2015 | 0 Comments

Join us for our May 13 webinar on How to Develop Fit-for-Purpose Quantitative IHC Assays to Enable Clinical Trial Patient Stratification. Dr. Sharon Moulis will be presenting how traditional methods of IHC assay design can be modified with the use of quantitative image analysis to develop robust and powerful quantitative IHC assays. These robust assays […]

Continue Reading

Join Definiens at Molecular Med Tri-Con 2015, February 16-18 in San Francisco, CA

| February 1, 2015 | 0 Comments

Visit Definiens at booth #423 at the Molecular Med-Tri-Con conference, February 16-18 to learn about Definiens’ comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections. At the conference we will be showcasing the latest imaging and analysis technologies which are revolutionizing research pathology, leading to breakthroughs in personalized medicine […]

Continue Reading

Upcoming Webinar from Definiens – Best Practices in IHC-based Tissue Image Analysis for Immuno-oncology, Oncology and Diabetes

| January 11, 2015 | 0 Comments

Presenters: Anindita Bhoumik, M.S., Scientist, R&D, ViaCyte, Inc. Jeff Dzubay, Ph.D., Field Application Scientist, Definiens Douglas Bowman, Associate Scientific Fellow, Takeda Pharmaceuticals International Co. Broadcast #1: Wednesday, January 14, 2015 2pm GMT (UK) / 3pm CET (EU-Central) / 9am EST (NA) Broadcast #2: Wednesday, January 14, 2015 1pm EST (NA) / 10am PST The use […]

Continue Reading

Definiens Releases Tissue Studio® 4.0 for Quantitative Digital Pathology

| December 8, 2014 | 0 Comments

 Continues Leadership in Simplifying Tissue Image Analysis and Improving Workflow Efficiency MUNICH — Definiens, the global leader in Tissue Phenomics® for oncology diagnostics announced the newest version of its leading image analysis software for quantitative digital pathology, Tissue Studio 4.0. The new release provides greater flexibility, more accurate and consistent results, and the ability to use any […]

Continue Reading